Symptoms of Low Vitamin K: Causes and Treatment
Deficiency
Symptoms & causes
Vitamin K deficiency is uncommon in healthy adults but is a genuine clinical risk in newborns, people on warfarin or antibiotics, and those with fat malabsorption; the distinction between K1 and K2 is important but often conflated in supplement marketing.
Vitamin K is a fat-soluble vitamin essential for blood clotting and bone health. While deficiency is rare in healthy adults, it poses serious risks for newborns, individuals on blood thinners like warfarin, and those with digestive disorders. This guide covers the symptoms, causes, and treatment of low vitamin K, including the critical interaction with GLP-1 medications.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Vitamin K β a fat-soluble vitamin existing in two primary dietary forms: K1 (phylloquinone β found in green leafy vegetables; the primary dietary form) and K2 (menaquinones β MK-4 through MK-13; found in fermented foods, animal products, especially natto, and produced by gut bacteria). Function: vitamin K is the essential cofactor for Ξ³-glutamyl carboxylase, the enzyme that carboxylates vitamin K-dependent proteins β the four coagulation factors (II, VII, IX, X), the anticoagulant proteins (C, S, Z), osteocalcin, and matrix Gla protein. Adequate intake: K1: 90β120 mcg/day for adults; no RDA established. No established UL for K1 or K2 from food or supplements. Rich K1 sources: kale, collard greens, spinach, broccoli, Brussels sprouts. K2 sources: natto, hard cheeses, egg yolks, butter, chicken liver. Gut bacteria produce K2 but bioavailability is limited and poorly understood.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Prolonged bleeding time and excessive bleeding from cuts
- Easy bruising and large bruises from minor trauma
- Heavy menstrual bleeding
- Nosebleeds
- Blood in urine or stool
- Elevated PT/INR on lab testing
- In newborns: bleeding from circumcision site, gastrointestinal bleeding, intracranial hemorrhage
Don't wait
See a doctor if
- Easy bruising without trauma
- Prolonged bleeding from wounds
- Blood in urine or stool
- Elevated PT/INR without anticoagulant medication use
- Newborns who did not receive the standard K1 injection at birth showing any bleeding signs
- People on warfarin who have eaten large amounts of vitamin K-rich foods and may have subtherapeutic INR
Who is most likely to run low
Some people are more prone to falling short than others β including many people on a weight-loss journey who are simply eating less.
- Newborns who did not receive K1 injection at birth
- Adults on warfarin
- People with fat malabsorption (Crohn's, CF, celiac, biliary disease)
- People on broad-spectrum antibiotics long-term
- Adults on very-low-fat diets for extended periods
- People taking cholestyramine
- People with chronic liver disease
What causes low Vitamin K β a fat-soluble vitamin existing in two primary dietary forms: K1 (phylloquinone β found in green leafy vegetables; the primary dietary form) and K2 (menaquinones β MK-4 through MK-13; found in fermented foods, animal products, especially natto, and produced by gut bacteria). Function: vitamin K is the essential cofactor for Ξ³-glutamyl carboxylase, the enzyme that carboxylates vitamin K-dependent proteins β the four coagulation factors (II, VII, IX, X), the anticoagulant proteins (C, S, Z), osteocalcin, and matrix Gla protein. Adequate intake: K1: 90β120 mcg/day for adults; no RDA established. No established UL for K1 or K2 from food or supplements. Rich K1 sources: kale, collard greens, spinach, broccoli, Brussels sprouts. K2 sources: natto, hard cheeses, egg yolks, butter, chicken liver. Gut bacteria produce K2 but bioavailability is limited and poorly understood.
- Newborn period β low placental transfer, low breast milk K1 content, sterile gut
- Fat malabsorption β Crohn's disease, celiac disease, cystic fibrosis, bile duct obstruction, short bowel syndrome
- Liver disease β impairs synthesis of K-dependent coagulation factors
- Prolonged broad-spectrum antibiotic use β kills K2-producing gut bacteria
- Medications that antagonize vitamin K: warfarin, some cephalosporin antibiotics
- Extremely low-fat diet over a prolonged period
- Cholestyramine use β reduces fat-soluble vitamin absorption
How low levels are diagnosed
Prothrombin time (PT) / INR β elevated when vitamin K-dependent coagulation factors are deficient. Direct measurement: plasma phylloquinone levels β rarely measured clinically. Functional markers for K2: percentage of uncarboxylated osteocalcin and uncarboxylated MGP β research tools, not routine clinical tests.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Food sources for K1: dark green leafy vegetables consumed with a fat source for optimal absorption. Supplementation: phylloquinone (K1) or MK-4/MK-7 (K2 forms); standard supplement doses for vitamin K1: 100β200 mcg/day for adults at risk; K2 supplement doses commonly used in bone and cardiovascular health trials: MK-7 at 90β360 mcg/day. CRITICAL: do not supplement vitamin K without clinician oversight if on warfarin or other vitamin K antagonists β even small consistent increases in vitamin K intake can significantly reduce anticoagulant efficacy. For severe deficiency with active bleeding: IV phytonadione under clinical supervision.
How to keep levels up
Regular consumption of dark green leafy vegetables. Vitamin K1 injection for all newborns at birth. For malabsorption: vitamin K monitoring and supplementation in clinical care. For people on warfarin: consistent dietary vitamin K intake β the goal is predictable coagulation, not elimination of vitamin K from the diet.
When to see a clinician
Any active or unexplained bleeding. All newborns: K1 injection at birth is standard care. People on warfarin: discuss all dietary vitamin K changes and vitamin K supplements with prescribing clinician before making changes. People with fat malabsorption: vitamin K status should be part of routine nutritional monitoring.
Vitamin K Deficiency Bleeding in Newborns: Why the Birth Injection Is Non-Negotiable
The most clinically serious vitamin K deficiency scenario isn't in adults β it's in the first hours and weeks of life. Newborns are uniquely vulnerable to vitamin K deficiency bleeding (VKDB), a condition that can cause catastrophic intracranial hemorrhage in otherwise healthy-appearing infants.
The biology is straightforward: maternal vitamin K does not cross the placenta well, breast milk contains very little K1, and the newborn gut is sterile at birth, meaning no K2-producing bacteria are present. This triple vulnerability means all newborns enter the world with functionally deficient vitamin K status. Without intervention, a percentage will bleed β and when they do, the consequences are often devastating.
VKDB presents in three forms. Early VKDB occurs within 24 hours of birth and is associated with maternal medications that interfere with vitamin K metabolism, particularly certain anticonvulsants. Classic VKDB appears between days 1 and 7, causing bleeding from the umbilical stump, circumcision site, or gastrointestinal tract. But the most dangerous form is late VKDB, striking between weeks 2 and 12. These infants β often exclusively breastfed and appearing perfectly healthy β can suffer sudden intracranial hemorrhage. The mortality rate approaches 20%, and many survivors have permanent neurological damage.
The prevention is remarkably simple and effective: a single intramuscular injection of 1 mg phytonadione (vitamin K1) given at birth. This intervention essentially eliminates VKDB and is considered one of the most effective perinatal interventions in all of medicine. Despite this, a small but vocal anti-injection movement has led some parents to refuse the shot. The consequences are documented: clusters of late VKDB have appeared in regions with higher opt-out rates, representing a preventable public health harm.
Bottom line
The vitamin K1 birth injection is one of the most effective and safest perinatal interventions in medicine β late VKDB causes intracranial hemorrhage in otherwise healthy breastfed infants and carries ~20% mortality; clusters of VKDB have been documented in regions where parents refused the injection.
Warfarin and Vitamin K: Why Consistent Intake Matters More Than Low Intake
For adults, the most clinically important vitamin K interaction isn't deficiency β it's the deliberate antagonism caused by warfarin. Warfarin works by inhibiting vitamin K epoxide reductase, the enzyme that recycles vitamin K after it's been used. This effectively depletes active vitamin K and reduces the liver's ability to produce functional clotting factors. The result is therapeutic anticoagulation β but it also means dietary vitamin K intake directly determines how well the drug works.
A persistent and dangerous myth tells warfarin patients to avoid vitamin K entirely. Many are instructed to eliminate kale, spinach, and other green vegetables from their diets. Current evidence and clinical guidance point in the opposite direction: the goal is consistent, stable vitamin K intake, not zero intake. When a patient eats a large amount of kale one day and none the next, their INR swings unpredictably. But when they eat a moderate, consistent amount of greens daily, their anticoagulation becomes predictable and manageable.
This has practical implications. Even a 100 mcg vitamin K supplement can meaningfully reduce INR, so warfarin patients should never start vitamin K supplements without explicit clinician oversight. But eating a small side of broccoli or spinach with dinner each night is not only safe β it's healthier than avoiding vegetables entirely. The key word is consistency. Large, irregular spikes in vitamin K intake are what cause dangerous INR fluctuations.
It's also worth noting that warfarin prescriptions have declined as direct oral anticoagulants like rivaroxaban, apixaban, and dabigatran have become more common. These newer drugs work through different mechanisms and do not interact with vitamin K, freeing patients from the dietary management burden that warfarin requires.
Bottom line
People on warfarin should aim for consistent daily vitamin K intake, not zero β large fluctuations in green vegetable consumption cause dangerous INR swings; consistent moderate intake allows stable and predictable anticoagulation.
K1 vs. K2: The Supplement Science Behind Bone Health and Vascular Calcification Claims
Walk into any supplement store and you'll find vitamin K2 marketed as a bone-building, artery-cleaning powerhouse. The biological mechanisms behind these claims are real and compelling. K2 forms, particularly MK-4 and MK-7, have longer half-lives and better tissue distribution than K1. They activate osteocalcin, the protein that binds calcium to bone matrix, and matrix Gla protein, which inhibits calcium deposition in arteries. When K2 is insufficient, these proteins remain uncarboxylated β and observational studies, most notably the Rotterdam Heart Study, have linked elevated uncarboxylated MGP to increased coronary artery calcification.
The supplement industry has built a substantial market on this mechanistic story. But the clinical trial evidence tells a more nuanced story. Supplementation with MK-7 at 90β360 mcg per day does reliably reduce uncarboxylated osteocalcin and uncarboxylated MGP β the biochemical markers improve. Whether this translates to fewer fractures or heart attacks is less clear. The most dramatic fracture prevention data comes from Japanese trials using MK-4 at 45 mg per day β a pharmacological dose that is roughly 100β500 times higher than what's in typical supplements. In Japan, this is a prescription drug for osteoporosis, not an over-the-counter supplement.
For cardiovascular outcomes, the evidence remains primarily observational. No large, powered randomized controlled trial has demonstrated that K2 supplementation reduces heart attacks, strokes, or cardiovascular mortality. The biology is plausible, the observational data is suggestive, but the definitive proof isn't there yet. This doesn't mean K2 is worthless β it means the marketing has outpaced the evidence. Consumers deserve to know that the supplement they're buying may improve lab markers without necessarily changing clinical outcomes.
Bottom line
K2's mechanisms are biologically compelling and supported by observational data, but RCT evidence for fracture reduction at typical supplement doses is not established; the pharmacological doses used in Japanese fracture trials are far above typical supplement doses.
Fat-Soluble Vitamin K and Malabsorption: The Clinical Risk Groups Who Need Monitoring
Vitamin K's status as a fat-soluble vitamin means it shares the same absorption requirements as vitamins A, D, and E. It needs dietary fat, bile acids, and a functioning intestinal surface to enter the bloodstream. When any of these are compromised, vitamin K deficiency can develop even in someone eating plenty of leafy greens β the problem isn't intake, it's absorption.
Several clinical conditions create this risk. Crohn's disease inflames the small bowel and reduces the absorptive surface area. Cystic fibrosis impairs pancreatic enzyme production, limiting fat digestion to the point where fat-soluble vitamin deficiencies β including vitamin K β are well-documented. Celiac disease causes villous atrophy that can persist until strict gluten avoidance allows healing. Biliary obstruction, whether from gallstones, strictures, or liver disease, prevents bile from reaching the intestine, and without bile, fat-soluble vitamins cannot be absorbed.
A less obvious risk comes from cholestyramine, a bile acid sequestrant used to lower cholesterol. By binding bile acids in the intestine, it intentionally prevents their reabsorption β but this also traps fat-soluble vitamins. Patients on long-term cholestyramine may need supplemental vitamin K, taken at least four hours apart from the medication to minimize the interaction.
Clinically, malabsorption-related vitamin K deficiency often presents subtly: unexplained easy bruising or a mildly elevated PT in someone with a known digestive condition who reports eating vegetables regularly. The key insight is that dietary intake isn't the issue β absorption is. These patients need monitoring and may require supplementation or specialized fat-soluble formulations.
Bottom line
Malabsorption from Crohn's, celiac, cystic fibrosis, or biliary disease impairs vitamin K absorption even when dietary intake is adequate β these patients need vitamin K status monitoring and may need supplementation or fat-soluble formulations.
Vitamin K and GLP-1 Therapy: Dietary Restriction, Fat Absorption, and the Warfarin Priority
GLP-1 receptor agonists like semaglutide and tirzepatide work partly by reducing appetite and caloric intake. For vitamin K, the primary concern isn't a direct drug interaction β it's the downstream effect of eating less food overall, and potentially less of the specific foods that provide vitamin K.
The good news is that vitamin K1 is extraordinarily abundant in green vegetables. A half-cup of cooked spinach provides roughly 444 mcg, far exceeding the adequate intake of 90β120 mcg per day. Even with significant dietary restriction, most people will still consume enough greens to meet their vitamin K needs. Frank deficiency from GLP-1 therapy alone is unlikely in patients who continue eating some vegetables.
The more important clinical scenario involves warfarin. A patient on both warfarin and a GLP-1 medication who substantially reduces their green vegetable intake will have less dietary vitamin K entering their system. This can raise their INR, potentially to dangerous levels. Conversely, if their appetite returns or they shift their diet again, their INR may drop. The prescribing clinician needs to know about the GLP-1 therapy and should monitor anticoagulation more frequently during the initial months of treatment, when dietary changes are most pronounced.
There is no direct pharmacokinetic interaction between vitamin K and GLP-1 drugs. Vitamin K is not extensively stored in adipose tissue, so weight loss doesn't release significant amounts into circulation the way it can for vitamin D. The interaction is entirely behavioral β mediated through changes in what and how much people eat.
Bottom line
People on both warfarin and GLP-1 therapy need anticoagulation monitoring during GLP-1 dietary changes β shifts in green vegetable consumption during appetite suppression directly affect warfarin efficacy via vitamin K intake changes.
What most pages leave out
The vitamin K2 supplement market consistently overstates the clinical fracture and cardiovascular evidence. Key facts omitted by supplement marketing: the dramatic fracture prevention data from Japanese K2 trials uses 45 mg MK-4/day β a prescription drug dose, not the 90β360 mcg in typical supplements; K2 cardiovascular evidence is primarily observational and not yet confirmed in powered RCTs; for warfarin patients, consistent moderate vitamin K intake is safer than vitamin K avoidance; and the K1 birth injection refusal movement has caused documented cluster outbreaks of intracranial hemorrhage in infants.
We flag this so you can make an informed choice β not to scare you off.
βFrequently Asked Questions
Easy bruising, prolonged bleeding from cuts, heavy menstrual bleeding, blood in urine or stool, elevated INR/PT on lab testing; in newborns not given the K1 injection, bleeding including intracranial hemorrhage.
K2 has biologically plausible mechanisms and observational data; RCT evidence for fracture reduction at supplement doses (90β360 mcg MK-7/day) is not definitive; the dramatic Japanese fracture trial data uses 45 mg MK-4/day, a prescription dose.
Yes; the goal is consistent daily vitamin K intake, not zero vitamin K; large inconsistent swings in green vegetable consumption cause INR instability; discuss any dietary changes with your prescribing clinician.
K1 (phylloquinone) is found in green leafy vegetables and is the primary blood-clotting form; K2 (menaquinones, especially MK-4 and MK-7) is found in fermented foods and animal products and is more relevant to bone and vascular health.
Newborns have very low vitamin K stores and cannot absorb adequate vitamin K from breast milk alone; the K1 injection at birth prevents hemorrhagic disease of the newborn, including intracranial hemorrhage; refusing it carries real and documented risks.
Natto is the richest source of K2. For K1, kale, collard greens, spinach, chard, Brussels sprouts, and broccoli are excellent sources.
Critically, with warfarin, even small doses reduce INR substantially; also with some cephalosporin antibiotics; does NOT interact with DOACs like rivaroxaban, apixaban, or dabigatran.
Not directly, but dietary changes during GLP-1 therapy can reduce K1 intake; for warfarin users, this shifts INR and requires anticoagulation monitoring; frank deficiency from GLP-1 dietary restriction is unlikely in most patients.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Vitamin C: Causes and Treatment
Vitamin C deficiency (scurvy) still occurs today, causing bleeding gums, fatigue, and poor wound healing. Learn the symptoms, causes, and evidence-based treatment.
Read moreSymptoms of Low Vitamin K2: Causes and Treatment
Vitamin K2 deficiency symptoms include easy bruising and bleeding. Learn who's at risk, how it differs from K1, and the critical warfarin interaction.
Read moreSymptoms of Low Vitamin B: Causes and Treatment
Vitamin B deficiency isn't one conditionβit's eight. Learn the distinct symptoms of B12, folate, B1, and B3 deficiency, who's at risk, and when to see a doctor.
Read moreSymptoms of Low Vitamin B2 (Riboflavin): Causes, Treatment, and Who Is at Risk
Riboflavin (B2) deficiency causes mouth sores, magenta tongue, and eye irritation. Learn who is at risk, how it's diagnosed, and how to treat it safely.
Read moreSymptoms of Low Vitamin B1 (Thiamine): Causes & Treatment
Thiamine deficiency can cause Wernicke encephalopathy, a medical emergency. Learn the symptoms of low vitamin B1, causes like alcohol use, and why IV treatment is critical.
Read moreSymptoms of Low Vitamin B3 (Niacin): Causes & Treatment
Niacin deficiency causes pellagraβthe 'four Ds': dermatitis, diarrhea, dementia, and death. Learn the symptoms, causes, and how treatment differs from high-dose niacin.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less β care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door β no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.